Bloomberg -- Roche Holding AG, the world’s biggest maker of cancer drugs, reported a 58 percent increase in first-half profit, helped by lower costs associated with the integration of Genentech.
Bloomberg -- Roche Holding AG, the world’s biggest maker of cancer drugs, reported a 58 percent increase in first-half profit, helped by lower costs associated with the integration of Genentech.
